2010 National Drug Strategy Household Survey Report[webpage]
Australian Institute of Health and Welfare, July 2011
This 2010 National Drug Strategy Household Survey report shows: positive and significant reductions since 2007 in daily tobacco smoking; mixed findings on alcohol consumption and risk; and a small overall rise in illicit drug use. In terms of attitudes to drugs, excessive alcohol use and tobacco smoking were nominated as the two most serious concerns to the community - and there were higher levels of support than previously for tobacco and alcohol harm reduction policies.
Balancing access and safety: meeting the challenge of blood borne viruses in prison [pdf]
Report for the ACT Government into implementation of a needle and syringe program at the Alexander Maconochie Centre. Public Health Association of Australia, July 2011
The Public Health Association of Australia (PHAA) was engaged by the ACT Government in May 2011 to investigate and report on models for the implementation of an NSP in the AMC. The project also entailed an assessment of barriers to implementation and broad consultations with key stakeholders. The emphasis of the project has been on seeking to develop a model that ensures optimal health and safety outcomes for everyone impacted upon by a custodial sentence. This includes not only the person being detained in custody but all prison staff and the broader community. This report outlines outcomes and recommendations from the project and proposes a way to meet this challenge.
The objective of this research was to collaborate with consumer and community representatives in the Alcohol and Pregnancy Project from 2006-2008 and evaluate researchers' and consumer and community representatives' perceptions of the process, context and impact of consumer and community participation in the project.
Australian Crime Commission, July 2011
The Illicit Drug Data Report is produced by the Australian Crime Commission (ACC) and is recognised as one of the most valuable tools for law enforcement agencies, policy and decision makers, research bodies and other stakeholders in combating illicit drugs. The report is designed to provide policy makers, resource planners, academia and law enforcement officials with a focused discussion of key drug issues and developments facing Australia. Identifying common elements, trends and streamlining the data collection process with the help of our state, territory and Commonwealth colleagues are practical ways in which organised crime’s illicit drug activity can be better anticipated, investigated and prevented.
A Matter of Balance: A background discussion paper to support the development of the National Pharmaceutical Drug Misuse Strategy (NPDMS) [webpage]
National Centre for Education & Training on Addiction, Flinders University, July 2011
A National Pharmaceutical Drug Misuse Strategy (NPDMS) is being developed at the request of the Ministerial Council on Drug Strategy (MCDS) and is funded through the MCDS Cost Shared Funding Model. The strategy development is being undertaken by a consortium led by the National Centre for Education and Training on Addiction (NCETA) at Flinders University. The project is being overseen by the Victorian Department of Health. This discussion paper provides a brief overview of issues relevant to the development of Australia’s NPDMS.The discussion paper outlines the background and context for the initiation of a pharmaceutical misuse strategy, relevant Australian and international research and data, and potential areas for prevention and remediation that may be addressed through the strategy.
National Opioid Pharmacotherapy Statistics Annual Data collection: 2010 report [webpage]
Australian Institute of health and welfare, July 2011
On a snapshot day in 2010 there were 46,078 clients who received pharmacotherapy for opioid dependence, of which almost two in three were male. This was an overall increase of just over 2,600 clients since 2009. This was accompanied by a rise in the number of prescribers from 1,435 in 2009 to 1,449 in 2010, with the majority of prescribers in 2010 being private prescribers (80%). Consistent with previous years, in 2010 methadone accounted for close to seven in 10 clients' pharmacotherapy type, with the remaining three in 10 clients receiving either buprenorphine or buprenorphine-naloxone.
Australian Injecting and Illicit Drug Users League for the Commonwelath Department of Health and Ageing, March 2011 (released July 2011)
This project implemented consumer participation demonstration projects in a variety of drug treatment settings in Australia. It followed the phase one research project which recommended a series of priority actions to support education and training in relation to consumer participation.
Project implementation in the alcohol and other drug field: enablers, barriers and sustainability [webpage]
Turning Poing Alcohol and Drug Centre, Released 2011
Since its inception in 2001 the Alcohol Education and Rehabilitation (AER) Foundation has funded more than 1,000 projects intended to reduce the burden of harm arising from alcohol and/or inhalant misuse in Australia. Turning Point Alcohol and Drug Centre was commissioned by the AER Foundation to synthesise and analyse evidence stored in AER electronic and paper databases to build an evidence-base from these projects.The report identifies mechanisms most frequently cited in project reports and evaluations as important to successful project implementation, or which were seen to constitute barriers to successful implementation (see table below). Additionally, each project was analysed by the research team to assess the extent to which project objectives had been achieved, with successful implementation defined as meeting 100% of project objectives.
This literature review was prepared as part of the development of the NPDMS. Its purpose is to inform and guide the development of the Strategy. Specifically, the review examines the extent and nature of the existing evidence base of relevance to the NPDMS. The literature review focuses primarily on opioids, benzodiazepines and codeine-containing analgesics as the Strategy, at the request of the MCDS, focus on these drugs.
[Page updated - 17 May 2012]
|
